The clinical trials and studies for the development of new medications include:
- Pharmacokinetic studies (determination of pharmacokinetic parameters; bioavailability including bioequivalences for generic medications; metabolism and metabolite identification).
- Consulting on methodology for clinical trial protocols.
- Phase I and phase II efficacy and tolerability trials.
- Abuse liability evaluation of new medications (psychopharmacological profile, studies of preference and discrimination).